Cooper Companies (The) (COO)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
$63.51-1.41%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · COO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -26.0% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 4.4% |
Growth built into the price is above our model estimate.
The price assumes 30.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 11 industry peers
COO — CEO transition
Dated 2026-10-27
CEO — Albert G. White III: The resignation of the President and CEO without an immediate permanent successor, requiring an interim Executive Chair and a search committee, represents a significant leadership disruption.
Why it matters: The company reaffirmed its year-end revenue range after Q3 growth slowed to 1%. The next report tests that outlook.
Watch forFiscal 2026 revenue is at least $4.229 billion and no more than $4.252 billion.
Also watch forFiscal 2026 revenue is below $4.229 billion or above $4.252 billion.
Why it matters: The new CEO will lead the effort to improve business results. A named leader would end the current search.
Supportive ifThe company names a permanent CEO and sets out clear plans to improve business results.
Worry ifNo permanent CEO is named by April 1, 2027, when Al White's advisor role ends.
Why it matters: CooperVision had no organic growth in Q3. Q4 guidance calls for a 2% decline to flat growth.
Supportive ifQ4 CooperVision organic revenue growth is above 0% year over year.
Worry ifQ4 CooperVision organic revenue falls more than 2% year over year, below the guided range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$123 on $10,000 · ±1.2% | How much price usually moves either way. |
| Bad day | $279 loss on $10,000 · 2.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,682 loss on $10,000 · 36.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.